Neoprobe changes name to Navidea Biopharmaceuticals

12/8/2011 | MedCityNews.com

Neoprobe has announced it has changed its name to Navidea Biopharmaceuticals. The name reflects the company's commitment to "NAVigating IDEAs" that allow for the transition of patient care innovations into the commercial market, the company said. CEO Mark Pykett said the company in January will "reveal a more complete view of the Navidea brand."

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations